These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19555850)

  • 21. [Prevention of cardiovascular events with antiplatelet drugs: aspirin (and others)?].
    Patrono C
    Minerva Cardioangiol; 1999 Nov; 47(11):389-90. PubMed ID: 10641409
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?
    Cleland JG
    Nat Clin Pract Cardiovasc Med; 2006 May; 3(5):234-5. PubMed ID: 16645645
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cardiovascular disease: an evidence-based clinical aid.
    Cradick NH
    Med J Aust; 2004 Feb; 180(4):197-8; author reply 198. PubMed ID: 14960146
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin in the primary prevention of vascular disease.
    Ambrosi P
    Lancet; 2009 Sep; 374(9693):877; author reply 879. PubMed ID: 19748391
    [No Abstract]   [Full Text] [Related]  

  • 26. An aspirin a day.
    Alderman C
    Nurs Stand; 1996 Jun; 10(39):25. PubMed ID: 8717972
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin resistance.
    Smout J; Stansby G
    Br J Surg; 2002 Jan; 89(1):4-5. PubMed ID: 11851656
    [No Abstract]   [Full Text] [Related]  

  • 28. Laboratory-defined aspirin resistance and recurrent cardiovascular events.
    Fontana P; Reny JL
    Arch Intern Med; 2008 Mar; 168(5):549-50. PubMed ID: 18332305
    [No Abstract]   [Full Text] [Related]  

  • 29. No easy way to identify aspirin resistance.
    Gibbings G
    Practitioner; 2008 Jul; 252(1708):6; author reply 6. PubMed ID: 18714510
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A revised health impact assessment of increased use of aspirin in Wales.
    Morgan G
    Public Health; 2012 Aug; 126(8):719-20. PubMed ID: 22613028
    [No Abstract]   [Full Text] [Related]  

  • 32. Life saving early and immediate aspirin: too little too late.
    Woollard M; Elwood PC; Morgan G
    Postgrad Med J; 2008 Jul; 84(993):337-8. PubMed ID: 18716010
    [No Abstract]   [Full Text] [Related]  

  • 33. Is aspirin resistance due to noncompliance?
    Dalen JE
    Arch Intern Med; 2008 Mar; 168(5):550; author reply 550. PubMed ID: 18332307
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug insight: aspirin resistance-fact or fashion?
    Maree AO; Cox D; Fitzgerald DJ
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):E1; author reply E2. PubMed ID: 17330121
    [No Abstract]   [Full Text] [Related]  

  • 35. Would it be more beneficial to take aspirin in the evening for prevention of cardiovascular diseases?
    Kriszbacher I; Koppán M; Bódis J
    J Vasc Surg; 2005 Feb; 41(2):375. PubMed ID: 15768027
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin in the secondary prevention of cardiovascular disease.
    Parekh AK; Galloway JM; Hong Y; Wright JS
    N Engl J Med; 2013 Jan; 368(3):204-5. PubMed ID: 23323896
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of aspirin in cardiovascular disease prevention.
    Wagenaar P
    Cardiovasc J Afr; 2012 Jun; 23(5):300. PubMed ID: 23077735
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical inquiries. Which healthy adults should take aspirin?
    Werner M; Kelsberg G; Weismantel AM; Aitken PV
    J Fam Pract; 2004 Feb; 53(2):146-50. PubMed ID: 14764301
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin: real benefits, but real risks, too.
    Harv Heart Lett; 1999 May; 9(9):1-3. PubMed ID: 10200029
    [No Abstract]   [Full Text] [Related]  

  • 40. Can the time of taking aspirin influence the frequency of cardiovascular events?
    Kriszbacher I; Ajtay Z; Koppán M; Bódis J
    Am J Cardiol; 2005 Aug; 96(4):608-10. PubMed ID: 16098324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.